Literature DB >> 26178725

Consumption of caffeinated and artificially sweetened soft drinks is associated with risk of early menarche.

Noel T Mueller1, David R Jacobs2, Richard F MacLehose2, Ellen W Demerath2, Scott P Kelly3, Jill G Dreyfus2, Mark A Pereira2.   

Abstract

BACKGROUND: Early menarche has been linked to risk of several chronic diseases. Prospective research on whether the intake of soft drinks containing caffeine, a modulator of the female reproductive axis, is associated with risk of early menarche is sparse.
OBJECTIVE: We examined the hypothesis that consumption of caffeinated soft drinks in childhood is associated with higher risk of early menarche.
DESIGN: The National Heart, Lung, and Blood Institute Growth and Health Study recruited and enrolled 2379 (1213 African American, 1166 Caucasian) girls aged 9-10 y (from Richmond, CA; Cincinnati, OH; and Washington, DC) and followed them for 10 y. After exclusions were made, there were 1988 girls in whom we examined prospective associations between consumption of caffeinated and noncaffeinated sugar- and artificially sweetened soft drinks and early menarche (defined as menarche age <11 y). We also examined associations between intakes of caffeine, sucrose, fructose, and aspartame and early menarche.
RESULTS: Incident early menarche occurred in 165 (8.3%) of the girls. After adjustment for confounders and premenarcheal percentage body fat, greater consumption of caffeinated soft drinks was associated with a higher risk of early menarche (RR for 1 serving/d increment: 1.47; 95% CI: 1.22, 1.79). Consumption of artificially sweetened soft drinks was also positively associated with risk of early menarche (RR for 1 serving/d increment: 1.43; 95% CI: 1.08, 1.88). Consumption of noncaffeinated soft drinks was not significantly associated with early menarche (RR for 1 serving/d increment: 0.88; 95% CI: 0.62, 1.25); nor was consumption of sugar-sweetened soft drinks (RR for 1 serving/d increment: 1.15; 95% CI: 0.95, 1.39). Consistent with the beverage findings, intakes of caffeine (RR for 1-SD increment: 1.22; 95% CI: 1.08, 1.37) and aspartame (RR for 1-SD increment: 1.20; 95% CI: 1.10, 1.31) were positively associated with risk of early menarche.
CONCLUSION: Consumption of caffeinated and artificially sweetened soft drinks was positively associated with risk of early menarche in a US cohort of African American and Caucasian girls.
© 2015 American Society for Nutrition.

Entities:  

Keywords:  aspartame; caffeine; diet; epidemiology; puberty; sugar-sweetened beverages

Mesh:

Substances:

Year:  2015        PMID: 26178725      PMCID: PMC4548172          DOI: 10.3945/ajcn.114.100958

Source DB:  PubMed          Journal:  Am J Clin Nutr        ISSN: 0002-9165            Impact factor:   7.045


  34 in total

1.  Rapid maturation of the reproductive axis during perimenarche independent of body composition.

Authors:  R S Legro; H M Lin; L M Demers; T Lloyd
Journal:  J Clin Endocrinol Metab       Date:  2000-03       Impact factor: 5.958

Review 2.  Examining the evidence for recent secular changes in the timing of puberty in US children in light of increases in the prevalence of obesity.

Authors:  John H Himes
Journal:  Mol Cell Endocrinol       Date:  2006-06-08       Impact factor: 4.102

3.  Disclosing caffeine action on insulin sensitivity: effects on rat skeletal muscle.

Authors:  Joana F Sacramento; Maria J Ribeiro; Sara Yubero; Bernardete F Melo; Ana Obeso; Maria P Guarino; Constancio Gonzalez; Silvia V Conde
Journal:  Eur J Pharm Sci       Date:  2015-02-03       Impact factor: 4.384

4.  Sources of data for developing and maintaining a nutrient database.

Authors:  S F Schakel; Y A Sievert; I M Buzzard
Journal:  J Am Diet Assoc       Date:  1988-10

5.  Skinfold equations for estimation of body fatness in children and youth.

Authors:  M H Slaughter; T G Lohman; R A Boileau; C A Horswill; R J Stillman; M D Van Loan; D A Bemben
Journal:  Hum Biol       Date:  1988-10       Impact factor: 0.553

6.  Stimulatory effect of caffeine on the hypothalamo-pituitary-adrenocortical axis in the rat.

Authors:  S A Nicholson
Journal:  J Endocrinol       Date:  1989-08       Impact factor: 4.286

7.  Indexes of obesity and comparisons with previous national survey data in 9- and 10-year-old black and white girls: the National Heart, Lung, and Blood Institute Growth and Health Study.

Authors:  B N Campaigne; J A Morrison; B C Schumann; F Falkner; E Lakatos; D Sprecher; G B Schreiber
Journal:  J Pediatr       Date:  1994-05       Impact factor: 4.406

Review 8.  Etiology of hormone receptor-defined breast cancer: a systematic review of the literature.

Authors:  Michelle D Althuis; Jennifer H Fergenbaum; Montserrat Garcia-Closas; Louise A Brinton; M Patricia Madigan; Mark E Sherman
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2004-10       Impact factor: 4.254

9.  Obesity and cardiovascular disease risk factors in black and white girls: the NHLBI Growth and Health Study.

Authors: 
Journal:  Am J Public Health       Date:  1992-12       Impact factor: 9.308

10.  Earlier menarche is associated with fatty liver and abdominal ectopic fat in midlife, independent of young adult BMI: The CARDIA study.

Authors:  Noel T Mueller; Mark A Pereira; Ellen W Demerath; Jill G Dreyfus; Richard F MacLehose; J Jeffrey Carr; James G Terry; David R Jacobs
Journal:  Obesity (Silver Spring)       Date:  2014-12-17       Impact factor: 9.298

View more
  14 in total

1.  Aspartic acid, phenylalanine, and early menarche.

Authors:  Ronald E Kleinman
Journal:  Am J Clin Nutr       Date:  2015-12       Impact factor: 7.045

2.  Reply to RE Kleinman.

Authors:  Noel T Mueller; Mark A Pereira
Journal:  Am J Clin Nutr       Date:  2015-12       Impact factor: 7.045

Review 3.  Early Life Exposures and Adult Cancer Risk.

Authors:  Megan A Clarke; Corinne E Joshu
Journal:  Epidemiol Rev       Date:  2017-01-01       Impact factor: 6.222

Review 4.  Artificial sweeteners and metabolic dysregulation: Lessons learned from agriculture and the laboratory.

Authors:  Jane Shearer; Susan E Swithers
Journal:  Rev Endocr Metab Disord       Date:  2016-06       Impact factor: 6.514

5.  Association between Dietary Patterns and Precocious Puberty in Children: A Population-Based Study.

Authors:  Chang Chen; Yao Chen; Yunting Zhang; Wanqi Sun; Yanrui Jiang; Yuanjin Song; Qi Zhu; Hao Mei; Xiumin Wang; Shijian Liu; Fan Jiang
Journal:  Int J Endocrinol       Date:  2018-01-16       Impact factor: 3.257

Review 6.  Noncaloric Sweeteners in Children: A Controversial Theme.

Authors:  Samuel Durán Agüero; Lissé Angarita Dávila; Ma Cristina Escobar Contreras; Diana Rojas Gómez; Jorge de Assis Costa
Journal:  Biomed Res Int       Date:  2018-01-08       Impact factor: 3.411

7.  Hypersensitivity reactions to food and drug additives: problem or myth?

Authors:  Laura Andreozzi; Arianna Giannetti; Francesca Cipriani; Carlo Caffarelli; Carla Mastrorilli; Giampaolo Ricci
Journal:  Acta Biomed       Date:  2019-01-29

8.  Maternal low-dose aspartame and stevia consumption with an obesogenic diet alters metabolism, gut microbiota and mesolimbic reward system in rat dams and their offspring.

Authors:  Jodi E Nettleton; Nicole A Cho; Teja Klancic; Alissa C Nicolucci; Jane Shearer; Stephanie L Borgland; Leah A Johnston; Hena R Ramay; Erin Noye Tuplin; Faye Chleilat; Carolyn Thomson; Shyamchand Mayengbam; Kathy D McCoy; Raylene A Reimer
Journal:  Gut       Date:  2020-01-29       Impact factor: 23.059

9.  Early Exposure to High-Sucrose Diet Leads to Deteriorated Ovarian Health.

Authors:  Giuliane Barros de Melo; Jéssica Furtado Soares; Thamyres Cristhina Lima Costa; Renata Ohana Alves Benevides; Caroline Castro Vale; Antonio Marcus de Andrade Paes; Renato Simões Gaspar
Journal:  Front Endocrinol (Lausanne)       Date:  2021-04-19       Impact factor: 5.555

Review 10.  Aspartame-True or False? Narrative Review of Safety Analysis of General Use in Products.

Authors:  Kamila Czarnecka; Aleksandra Pilarz; Aleksandra Rogut; Patryk Maj; Joanna Szymańska; Łukasz Olejnik; Paweł Szymański
Journal:  Nutrients       Date:  2021-06-07       Impact factor: 5.717

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.